Merck (MRK) Share-based Compensation Growth (5y) (2014 - 2026)

Merck (MRK) Share-based Compensation Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 10.76%
Dec 31, 2025 12.85%
Sep 30, 2025 10.12%
Jun 30, 2025 12.29%
Mar 31, 2025 12.54%
Dec 31, 2024 17.92%
Sep 30, 2024 14.06%
Jun 30, 2024 12.83%
Mar 31, 2024 13.61%
Dec 31, 2023 13.93%
Sep 30, 2023 12.50%
Jun 30, 2023 13.43%
Mar 31, 2023 12.63%
Dec 31, 2022 12.63%
Sep 30, 2022 12.83%
Jun 30, 2022 10.81%
Mar 31, 2022 10.15%
Dec 31, 2021 9.67%
Sep 30, 2021 8.73%
Jun 30, 2021 10.53%